BioCryst Pharmaceuticals, Inc. (BCRX): Price and Financial Metrics
BioCryst Pharmaceuticals, Inc. (BCRX)
Today's Latest Price: $8.80 USD
0.21 (2.44%)
Updated Jan 15 4:00pm
Add BCRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BCRX Stock Summary
- Of note is the ratio of Biocryst Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; just 18.83% of US stocks have a lower such ratio.
- BCRX's price/sales ratio is 28.34; that's higher than the P/S ratio of 91.87% of US stocks.
- Revenue growth over the past 12 months for Biocryst Pharmaceuticals Inc comes in at 352.07%, a number that bests 97.98% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Biocryst Pharmaceuticals Inc, a group of peers worth examining would be XFOR, PTCT, LOGC, DRRX, and MGEN.
- BCRX's SEC filings can be seen here. And to visit Biocryst Pharmaceuticals Inc's official web site, go to www.biocryst.com.
BCRX Stock Price Chart Interactive Chart >
BCRX Price/Volume Stats
| Current price | $8.80 | 52-week high | $8.99 |
| Prev. close | $8.59 | 52-week low | $1.58 |
| Day low | $8.39 | Volume | 5,880,400 |
| Day high | $8.99 | Avg. volume | 4,471,240 |
| 50-day MA | $6.38 | Dividend yield | N/A |
| 200-day MA | $4.66 | Market Cap | 1.55B |
BioCryst Pharmaceuticals, Inc. (BCRX) Company Bio
Biocryst Pharmaceuticals designs, optimizes and develops novel small molecule drugs that block key enzymes involved in rare diseases. The company was founded in 1986 and is based in Durham, North Carolina.
Loading social stream, please wait...